Ttbio Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Ttbio has a total shareholder equity of NT$292.6M and total debt of NT$167.3M, which brings its debt-to-equity ratio to 57.2%. Its total assets and total liabilities are NT$589.1M and NT$296.4M respectively.
Anahtar bilgiler
57.2%
Borç/özkaynak oranı
NT$167.33m
Borç
Faiz karşılama oranı | n/a |
Nakit | NT$65.93m |
Eşitlik | NT$292.64m |
Toplam yükümlülükler | NT$296.42m |
Toplam varlıklar | NT$589.07m |
Son finansal sağlık güncellemeleri
Recent updates
Here's Why Ttbio (GTSM:6493) Can Afford Some Debt
Apr 30Should Ttbio Corp. (GTSM:6493) Be Part Of Your Dividend Portfolio?
Mar 31Will Ttbio's (GTSM:6493) Growth In ROCE Persist?
Feb 03Ttbio (GTSM:6493) Is Growing Earnings But Are They A Good Guide?
Dec 22Ttbio Corp.'s (GTSM:6493) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Dec 03Should Ttbio Corp. (GTSM:6493) Be Part Of Your Dividend Portfolio?
Nov 18Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 6493's short term assets (NT$329.3M) exceed its short term liabilities (NT$170.1M).
Uzun Vadeli Yükümlülükler: 6493's short term assets (NT$329.3M) exceed its long term liabilities (NT$126.3M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 6493's net debt to equity ratio (34.7%) is considered satisfactory.
Borcun Azaltılması: 6493's debt to equity ratio has increased from 28.7% to 57.2% over the past 5 years.
Borç Kapsamı: 6493's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: Insufficient data to determine if 6493's interest payments on its debt are well covered by EBIT.